The second is dose and route translation : even where an effect is real in a mouse, the human-equivalent dose is not a simple body-weight scaling, and as the route section above stressed there is no human bioavailability figure to anchor an oral-versus-injected comparison
Maintenance phase: After noticeable improvement, some protocols suggest reducing to 2-6 mg per month , adjusted according to clinical evaluation
B12 deficiency elevates homocysteine, a sulfur-containing amino acid that damages arterial endothelium and increases atherosclerosis risk
The injections are administered via thin needles into subcutaneous fat (e.g., upper arms, thighs, stomach) or near an injury, not into a vein
There is no validated, publicly available reconstitution protocol for retatrutide, as it is an unlicensed investigational compound in the UK that may only be prepared by trained personnel within an approved clinical trial